These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2792662)

  • 21. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
    Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP
    Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion.
    Dreyfuss D; Leviel F; Paillard M; Rahmani J; Coste F
    Am Rev Respir Dis; 1988 Sep; 138(3):583-9. PubMed ID: 3059874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of vasopressin in the impaired water excretion of glucocorticoid deficiency.
    Linas SL; Berl T; Robertson GL; Aisenbrey GA; Schrier RW; Anderson RJ
    Kidney Int; 1980 Jul; 18(1):58-67. PubMed ID: 7218660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW; Fassett RG; Ohara M; Martin PY
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism.
    Chen YC; Cadnapaphornchai MA; Yang J; Summer SN; Falk S; Li C; Wang W; Schrier RW
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F672-8. PubMed ID: 15914774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
    László FA; Baláspiri L
    Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.
    Xu L; Carter EP; Ohara M; Martin PY; Rogachev B; Morris K; Cadnapaphornchai M; Knotek M; Schrier RW
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1110-5. PubMed ID: 11097630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sodium in clinics and complications of liver cirrhosis].
    Petrova D; Kolarski V; Todorov A
    Vutr Boles; 2000; 32(1):37-40. PubMed ID: 11195196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
    László FA; Csáti S; Baláspiri L; Manning M
    Acta Med Hung; 1984; 41(1):65-73. PubMed ID: 6739224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats.
    Ishikawa S; Schrier RW
    Kidney Int; 1982 Dec; 22(6):587-93. PubMed ID: 7162034
    [No Abstract]   [Full Text] [Related]  

  • 34. Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin.
    Saito T; Ishikawa SE; Ando F; Okada N; Nakamura T; Kusaka I; Higashiyama M; Nagasaka S; Saito T
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4034-40. PubMed ID: 9814488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis.
    Linas SL; Anderson RJ; Guggenheim SJ; Robertson GL; Berl T
    Kidney Int; 1981 Aug; 20(2):173-80. PubMed ID: 7289402
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
    Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
    J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water balance in the Brattleboro rat: considerations for hormone replacement therapy.
    Kinter LB
    Ann N Y Acad Sci; 1982; 394():448-63. PubMed ID: 6960776
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased gene expression of water channel in cirrhotic rat kidneys.
    Asahina Y; Izumi N; Enomoto N; Sasaki S; Fushimi K; Marumo F; Sato C
    Hepatology; 1995 Jan; 21(1):169-73. PubMed ID: 7528708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
    Mulinari RA; Gavras I; Wang YX; Franco R; Gavras H
    Circulation; 1990 Jan; 81(1):308-11. PubMed ID: 2404626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance.
    Sinha VK; Ko B
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):361-7. PubMed ID: 26311597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.